Alberto Espay is a Neurologist in Cincinnati, Ohio. Espay has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. He is also highly rated in 62 other conditions, according to our data. His top areas of expertise are Parkinson's Disease, Drug Induced Dyskinesia, Focal Dystonia, Torticollis, and Deep Brain Stimulation. Espay is currently accepting new patients.
Bastiaan Bloem practices in Nijmegen, Netherlands. Bloem is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. They are also highly rated in 18 other conditions, according to our data. Their top areas of expertise are Parkinson's Disease, Herpes Zoster Oticus, Drug Induced Dyskinesia, Deep Brain Stimulation, and Sacral Nerve Stimulation.
Chin-hsien Lin practices in Taipei, Taiwan. Lin is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Herpes Zoster Oticus, Parkinson's Disease, Hallervorden-Spatz Disease, Drug Induced Dyskinesia, and Deep Brain Stimulation.
Summary: In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). The study will focus on participants with a specific genetic variant in their LRRK2 gene. The main question researchers are trying to answer is if taking BIIB122 slows the worsening of PD more than placebo in the early stages of PD. To help answer this question, r...
Summary: In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). In this study: Participants will take 225 milligrams (mg) of BIIB122 or a placebo as tablets by mouth. A placebo looks like the study drug but has no real medicine in it. Participants will take BIIB122 or placebo 1 time a day for up to a minimum of 48 weeks and a ...
Published Date: May 12, 2022
Published By: Genetic and Rare Diseases Informnation Center